Cluster of Excellence Precision Medicine in Chronic Inflammation (PMI)

About the Cluster

More and more people in industrial nations are suffering from chronic inflammatory diseases such as Crohn’s disease, psoriasis, diabetes and rheumatism. In the Cluster of Excellence 2167 “Precision Medicine in Chronic Inflammation” (PMI), scientists from various medical disciplines and fundamental research are working together on an interdisciplinary basis to significantly improve the diagnosis, treatment and prevention of these diseases. Their vision is to achieve complete control over the diseases – at every stage and as early as possible.

More about the Cluster of Excellence Precision Medicine in Chromic Inflammation (PMI)

Why precision medicine?

Precision medicine and PMI

Cluster news

06.11.2025
[EN]

New Study Uncovers Molecular Drivers of Long COVID

Researchers from Borstel, Lübeck, and Kiel identify two key messengers that trigger persistent inflammation in the nasal mucosa.

 

 
15.10.2025
Double portrait

Boost for Microbiome Research in Kiel: DFG Funds New Analysis Platform

New microbiome platform at Kiel University enables interdisciplinary and more comprehensive microbiome analyses

 
08.10.2025
microscopic image

Double Risk: Combination of Two Genetic Variants Promotes Inflammation and Cancer

Research team in Kiel identifies two genetic alterations that, when combined, may increase the risk of colorectal cancer in people with chronic inflammatory bowel diseases.

 

 
02.10.2025
[EN]

Retreat in Travemünde

Two days full of exchange, new ideas, and joint planning: The cluster meeting prepared members for the upcoming funding period and provided space for inspiration and networking.

 

More Cluster NEws